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6992 | Chem. Sci., 2019, 10, 6992–700tabolic fate of monosaccharides in
cell membranes with glycomic and glycoproteomic
analyses†
Gege Xu, a Maurice Wong,a Qiongyu Li, a Dayoung Park, a Zhi Chenga
and Carlito B. Lebrilla*abc
Cell membrane protein glycosylation is dependent on the metabolic state of the cell as well as exogenous
nutrients available. Although the metabolism and interconversion of monosaccharides have been well-
studied, their incorporation into cell surface glycans and their corresponding glycoproteins remains
relatively unknown. In this study, we developed a method to investigate quantitatively the incorporation
pathways of dietary saccharides into specific glycans and glycoproteins on the cell membrane by
treating intestinal Caco-2 and hepatic KKU-M213 cells with 13C-labeled monosaccharides and
characterizing the resulting cell surface glycans and glycopeptides by LC-MS/MS. Time-course studies
using uniformly labeled glucose revealed that the rate of incorporation was both glycan-specific and
protein-dependent. Comparative studies using different dietary saccharides and multiple cell lines
revealed the variance of monosaccharide utilization and interconversion in different tissues and
organisms. The robust isotope-labeling and glycan profiling methods can provide a useful tool for
differentiating glycosylation pathways and enhance the understanding of how dietary sugar intake affects
health.Introduction
The utilization of monosaccharides through cell metabolism is
a fundamental process in diet and nutrition.1–4 Previous studies
have focused primarily on glycolysis and the fate of glucose
through now established basic cellular pathways. Both stable
and radioactive isotope labeling have been used to determine
with great detail the fate of specic components of glucose and
its metabolic products.5,6 Less is known about how mono-
saccharides are utilized to produce glycoconjugates. Human
proteins are largely glycosylated, with glycans rening and
dening the protein functions. Monosaccharides like amino
acids, can be directly incorporated into proteins. While the
incorporation of amino acids is well known,7 incorporation of
monosaccharides into glycans is relatively unexplored. Only
recently, comprehensive glycomic and glycoproteomic proling
methods have beenmade available to allow isotopic enrichment
studies of glycans.ifornia, One Shields Avenue Davis, Davis,
.edu
Medicine, University of California, Davis,
lifornia, Davis, CA 95616, USA
on (ESI) available: Supplementary
: 10.1039/c9sc01653h
2As one of the key components of plasma membrane, cell
surface glycoproteins are known to be closely related to basic
functions of the cell such as proliferation, differentiation, and
cell–cell and cell–microbe interactions.8–11 Biosynthesis of cell
membrane glycoproteins requires both glycan-processing
enzymes including glycosyltransferases and glycosidases, and
activated nucleotide sugars as glycosylation precursors.12,13
Although these monosaccharide donors can be salvaged from
degraded glycans within the cell, the major source of glycosyl-
ation precursors is the external sugars that are imported into
the cell.14,15 Therefore, glycosylation pattern on the cell surface
is greatly dependent on both the metabolic state of the cell and
the types of exogenous nutrients available.16–18 Mono-
saccharides such as glucose and fructose are the major carbon
sources for most organisms and can participate in the biosyn-
thesis of both the peptide and the glycan parts of glycopro-
teins.19–21 However, our recent study has shown that the use of
certain sugars such as fructose and galactose as a carbon source
can introduce signicant changes on membrane protein
glycosylation and thereby affect epithelial cell functions.16Other
studies have also indicated that high fructose supplementation
can induce an aggressive phenotype in breast tumor cells and
increase the incidence of inammation in patients with chronic
kidney disease.22–24 To fully understand the effects of dietary
saccharides on cell surface glycosylation and various cellular
functions, it will be helpful to elucidate the metabolic pathways
of these sugars to glycoproteins.This journal is © The Royal Society of Chemistry 2019
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View Article OnlineBesides glucose, isotopically labeled monosaccharides have
been used as tracers to study metabolic pathways in the cell and
turnover rates of specic compounds.25–30 Earlier glycoprotein
studies used radioactive isotope-labeled monosaccharides such
as 14C-glucosamine, 3H-galactose and 14C-mannose to deter-
mine the incorporation of sugars to cell surface glycopro-
teins.31–36 Using these approaches, the metabolism and
interconversion of common monosaccharides have been
revealed, while the relative contributions of each pathway
remain unknown. Moreover, the radioactive isotope-labeling
methods could only provide the amount of incorporation at
the total protein level. The incorporation of these mono-
saccharides into other groups of compounds, such as lipids,
could greatly interfere with the quantitative results. More
recently, labeling approaches employing stable isotope-labeled
compounds and mass spectrometry detection have been
developed to study the metabolism of carbohydrates and their
metabolic pathways to glycoconjugates.37–40 For example, Ichi-
kawa et al. studied the metabolic origins of mannose in glyco-
proteins by analyzing the mannose residues hydrolyzed from
released N-glycans of 1,2-13C-glucose or 4-13C-mannose treated
cells using GC-MS.40 Although the direct contribution of
mannose to glycoprotein synthesis was estimated using this
method, the incorporation of glucose andmannose into specic
glycans and their parental glycoproteins were unknown. A more
recent study by Xiao and Wu investigated the degradation and
synthesis rates of glycoproteins using stable isotope labeling
with amino acids in cell culture (SILAC) approach followed by
LC-MS/MS analysis of deglycosylated peptides.41 This method,
however, cannot be used for studying the metabolic pathways of
monosaccharides and the effects of glycan composition on
glycoprotein turnover.
In this study, we investigated the incorporation efficiencies
and kinetics of common monosaccharides into specic glycans
and glycoproteins on cell membrane by treating human intes-
tinal and hepatic cells with 13C-labeled monosaccharides. Using
recently developed glycomic and glycoproteomic analyses
workows,42 we identied the incorporation mechanisms of the
different monosaccharides to specic glycans and glycoproteins
using their MS and MS/MS spectra. Time-course studies using
uniformly labeled 13C-glucose provided glycan- and protein-
specic information on the turnover kinetics of cell surface
glycoproteins. Incorporation levels of different saccharides in
different cell lines were quantied to investigate the metabolic
fates of common saccharides.
Results and discussion
Identication of 13C-Labeled glycans and glycopeptides
A workow for the identication of 13C-labeled glycans and
glycopeptides is shown in Fig. S1.† For each experiment, cells
were cultured in either normal media with unlabeled glucose as
controls or treated by media supplemented with uniformly
labeled 13C-monosaccharides. Aer treatment for 3 to 96 hours
with 13C-glucose or 72 hours with other 13C-labeled mono-
saccharides, 13C-isotopes were metabolically incorporated into
the cell surface glycoproteins. Intact glycopeptides and releasedThis journal is © The Royal Society of Chemistry 2019glycans from both the control and the treated samples were
analyzed by LC-MS/MS as described, with the cell surface
glycopeptides and glycans in the controls identied using their
accurate masses and tandem MS spectra. The N-glycomic and
glycoproteomic proles of Caco-2 and M213 cells presented in
this work have also been obtained previously.42 The retention
times and monoisotopic peaks in both control and labeled
compounds were used to identify the labeled species. By
comparing the isotope distributions of each compound from
the control and the treated samples, 13C-labeled glycans and
glycopeptides were identied and further conrmed by their
respective tandem MS spectra.Elucidation of isotopic incorporation
Exogenous dietary monosaccharides such as glucose, galactose,
mannose, and fructose can be transported across the plasma
membrane into the cell and converted to their phosphorylated
forms (Fig. S2†) before they participate in glycoprotein synthesis
via three different pathways: glycolysis, salvage or direct acti-
vation to the same sugar donors, and conversion to other acti-
vated sugar donors. The rst pathway (glycolysis) will result in
an increase in the molecular weights of glycans and glycopep-
tides by different mass units (M + x) while the latter two path-
ways will incorporate intact monosaccharides resulting in
a mass increase in multiples of six (M + n  6). The three
incorporation mechanisms can be elucidated by the MS and
MS/MS spectra of glycans and glycopeptides with 13C incorpo-
ration. Fig. 1a and b shows an example of the differential
incorporation mechanisms revealed by the mass spectra of
a high mannose type N-glycan, Man8GlcNAc2, detected in
13C-
fructose-treated Caco-2, an epithelial colorectal adenocarci-
noma cell line, and M213, an intrahepatic cholangiocarcinoma
cell line, respectively. In the intestinal epithelial cell, the 13C-
incorporated Man8GlcNAc2 had a continuous isotope distribu-
tion ranging from m/z 874 to m/z 893, corresponding to the
incorporation of 13C into approximately 26 to 64 of carbons in
this glycan. The continuous and uniform distribution demon-
strated incorporation through glycolysis. In the hepatic M213
cell, however, a combination of continuous and discrete isotope
distribution ranging from m/z 864 to m/z 891, with mass
increments of six (M + n  6) was observed for this N-glycan
indicating the intact conversion of fructose into mannose and
GlcNAc residues. These results demonstrated the differential
utility of fructose in cells from different tissues.
More detailed information regarding the incorporation
pathways were obtained from MS/MS spectra of the specic
glycans labeled with 13C. Fig. 1c shows the MS/MS spectrum of
a fucosylated complex-type N-glycan, Hex5HexNAc4Fuc1, from
13C-galactose-treated M213 cell with a precursor m/z of 897.35.
Compared to its monoisotopic molecular ion with a m/z of
894.34 (z ¼ 2), six carbons were 13C-labeled. The MS/MS spec-
trum containing fragment ions with m/z 204.08 (HexNAc),
366.14 (HexNAc + Hex), and 372.16 (HexNAc + Hex + 6 13C)
revealed that all of the labeled carbons were on a hexose
residue. Because 13C-galactose was only slightly incorporated
into the high mannose glycan from the same M213 cell sample,Chem. Sci., 2019, 10, 6992–7002 | 6993
Fig. 1 MS and MS/MS spectra for the elucidation of incorporation mechanisms. (a) MS spectrum of N-glycan Man8GlcNAc2 from
13C-fructose-
treated Caco-2 cell. (b) MS spectrum of N-glycan Man8GlcNAc2 from
13C-fructose-treated M213 cell. (c) MS/MS spectrum of N-glycan Hex5-
HexNAc4Fuc1 (precursorm/z 897.35) from
13C-galactose-treated M213 cell. (d) MS/MS spectrum of N-glycan Hex5HexNAc4Fuc1 (precursorm/z
919.41) from 13C-mannose-treated M213 cell.
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View Article Onlinewe concluded that 13C-galactose was mainly utilized through
direct incorporation as an intact galactose residue in hepatic
cell. In contrast, when M213 cells were treated with 13C-
mannose, fragment ions with both increments of six (m/z
210.11, HexNAc + 6 13C; m/z 372.16, HexNAc + Hex + 6 13C; m/z
378.18, HexNAc + Hex + 12 13C) corresponding to intact incor-
poration and increments of one (indicated by red arrows in
Fig. 1d) corresponding to incorporation by glycolysis were
observed for glycan composition Hex5HexNAc4Fuc1 with m/z
919.41 (50 carbons incorporated with 13C) (Fig. 1d). The
comparison and combination of information from MS and MS/
MS spectra provided extensive elucidation of incorporation6994 | Chem. Sci., 2019, 10, 6992–7002pathways for saccharides from different sources and cell lines of
different tissues.Quantitation of incorporation efficiency
To compare the incorporation behavior and metabolic path-
ways associated with different 13C-labeled saccharides in
different cell lines, a method for quantitative measurement of
incorporation efficiency is necessary. As illustrated in Fig. 2, two
quantitation approaches were used in this study depending on
the extent of 13C-incorporation. In the rst method where most
of the carbons in the glycan or glycopeptide were labeled by 13CThis journal is © The Royal Society of Chemistry 2019
Fig. 2 Two approaches for the quantitation of incorporation efficiency. (a) Quantitation using the peak areas obtain from the EICs of the same
compound from labeled and unlabeled samples. (b) Quantitation using the summed normalized abundances of the same compound from
labeled and unlabeled samples.
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View Article Onlineand the isotope distribution of the labeled compound had no
overlap with its original isotopic peaks (Fig. 2a), chromato-
grams were extracted for the m/z ranges with and without
labeling. Peak areas obtained by manual integration of the EICs
were used to calculate the percentage of 13C-labeled
compounds. Fractional incorporation was then obtained by
subtracting the (%)-labeled value of the control sample from
that of the treated sample to correct the error caused by possible
noise peaks. This approach, however, is less accurate when the
isotopic distributions of the labeled and unlabeled compounds
overlap. Consequently, the averaged isotope distributions ob-
tained from MS spectra of the same compound were compared
between the control and the treated samples aer all the
isotopes were normalized to their respective monoisotopic
peaks (Fig. 2b). By comparing the summed normalized abun-
dances of all isotopes from the two samples, the percent
incorporation is determined more accurately.Time-course study to obtain incorporation kinetics
Although it was shown that each cell line has a unique and
essentially constant glycosylation prole until they were sub-
cultured at higher passages,16,43 the cell surface glycoproteins
are known to be constantly renewing in living cells. Factors such
as the structures of attached glycoforms and the interactions
between glycoprotein and ligands can greatly affect the stability
and turnover rate of a glycoprotein.44 By proling theThis journal is © The Royal Society of Chemistry 2019incorporation kinetics of uniformly labeled 13C-glucose to cell
surface glycans and glycoproteins through a time-course study,
we can elucidate the turnover rates of different glycoproteins
and glycan structures. Fig. 3a shows the incorporation of 13C-
glucose into a high mannose type N-glycan, Man9GlcNAc2,
from hepatic M213 cell, aer 3 to 96 hours of treatment. The
incorporation level of this glycan was found to be approximately
60% aer the cell was cultured in 13C-glucose-containing
medium for only three hours, indicating the rapid turnover
rates of membrane glycoproteins with this glycoform. MS
spectra from different time points revealed that the dominant
incorporation mechanism of 13C-glucose during the rst few
hours was intact conversion because the isotope distribution
showed distinct mass increments of six. Starting from approx-
imately 12 hours, however, glycolysis becomes the major
incorporation pathway. Aer 72 to 96 hours of treatment, the
13C-incorporation efficiency reached 100%, and the ion withm/z
977.45, corresponding to Man9GlcNAc2 with all 70 carbons
isotopically labeled was the highest peak.
To evaluate and compare the turnover rates of different
glycan types, we calculated the incorporation rates of ve high-
mannose-type N-glycans containing two GlcNAc residues and
ve to nine mannose residues, two fucosylated-only complex
type N-glycans, Hex5HexNAc4Fuc1 and Hex5HexNAc4Fuc2, and
two fucosylated and sialylated complex type N-glycans, Hex5-
HexNAc4Fuc1NeuAc1 and Hex5HexNAc4Fuc1NeuAc2, from M213Chem. Sci., 2019, 10, 6992–7002 | 6995
Fig. 3 Time-course study of incorporation kinetics of cell surface glycans. (a) MS spectra of N-glycan Man9GlcNAc2 fromM213 cell after 3 to 96
hours of treatment with 13C-glucose. (b) Rates of 13C-incorporation into different types of N-glycans.
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View Article Onlinecell. The incorporation rates of 13C-glucose into various glycans
were graphed against treatment time for the cell (Fig. 3b). In
general, the turnover rates of different types of N-glycans were
consistent with their synthesis and maturation pathways.45–47
The fastest rate of incorporation within this group was for
Man9GlcNAc2 which is the glycan synthesized in the earliest
part of the glycosylation process, while still in the endoplasmic
reticulum (ER). The fast rate of incorporation means high
turnover rate due to both the high synthesis rate of the glycan6996 | Chem. Sci., 2019, 10, 6992–7002and perhaps the rapid degradation rate of the attached
proteins. While another high mannose N-glycan, Man8GlcNAc2,
is also produced in the ER, but it had a slightly lower turnover
rate due potentially to the extra enzymatic processing step by a-
mannosidase I. Similarly, the other high mannose glycans,
Man7GlcNAc2, Man6GlcNAc2, and Man5GlcNAc2 had decreasing
turnover rates. In general, the high mannose type glycans
turned over within the rst three hours, signicantly faster than
the fucosylated and sialylated complex type glycans. The latterThis journal is © The Royal Society of Chemistry 2019
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View Article Onlinegroups are modied in the Golgi and therefore require more
enzymatic processing steps. The lower turnover rates of sialy-
lated glycans were also consistent with previous ndings that
terminally charged glycans can extend the circulatory half-life of
glycoproteins.48 Nonetheless, the incorporation levels of all the
glycans reached >90% aer 48 hours and approximately 100%
aer 72 hours, indicating all the cell surface glycoproteins were
turned over.
Glycoprotein turnover rates are closely related to glycan types
but can vary more with protein structures, functions, and
localization. With comprehensive glycoproteomic analysis of
the untreated cells, we can prole the turnover rates of specic
glycoproteins. For example, integrins are a group of cell surface
glycoproteins that play important parts in cell–cell adhesion
and intracellular signaling.11,49 Each integrin consists of an
alpha and a beta subunit that are both highly glycosylated.50,51
Fig. 4 shows the differential turnover rates of three glycopep-
tides from different integrin subunits, a6, a3, and b1, found on
M213 cell. Aer ve hours of treatment with 13C-glucose, both
the a3 and b1 subunits were 100% exchanged, while subunit a6
was only 32% labeled although all three glycopeptides carried
a high mannose type N-glycan. These results showed that the a3Fig. 4 13C-incorporation into integrin glycopeptides from M213 cell tre
This journal is © The Royal Society of Chemistry 2019and b1 subunits in M213 cell have similar metabolic behavior,
consistent with the two subunits being in the same integrin
protein complex. The isotopic distribution for the a3 and b1
subunits spanned up to around m/z 994 and 1377, respectively,
corresponding to a total of 75 labeled carbons in the glyco-
peptides. Compared to the incorporation prole of the glycan
alone (Fig. 3a) where the majority of the 70 carbons from
Man9GlcNAc2 were labeled aer six hours, the glycopeptide
proles showed that the 13C-incorporation occurred mainly on
the glycan side accompanied with minor incorporation on the
polypeptide.Differential metabolic fates of monosaccharides in various
cell lines
With the qualitative and quantitative methods described above
to characterize the incorporation mechanisms and efficiencies,
we studied the incorporation behavior of four common dietary
monosaccharides, glucose, galactose, fructose, and mannose,
in different cell lines. MS spectra of two N-glycans, Man8-
GlcNAc2 and Hex5HexNAc4Fuc1NeuAc1, from intestinal Caco-2
cells and hepatic M213 cells aer treatment with these fourated with 13C-glucose for five hours.
Chem. Sci., 2019, 10, 6992–7002 | 6997
Fig. 5 Incorporation of 13C-labeled glucose, mannose, galactose, and fructose into a high mannose typeN-glycan fromCaco-2 and M213 cells.
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O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
1 
Ju
ne
 2
01
9.
 D
ow
nl
oa
de
d 
on
 8
/2
/2
01
9 
10
:1
2:
02
 A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online13C-labeledmonosaccharides are shown in Fig. 5 and S3.†Using
the MS spectra and EICs of labeled and unlabeled compounds,
the incorporation levels as well as the averaged percentage of
13C-replaced carbons were calculated as shown in Table 1. As
the major energy and carbon source for most organisms,
glucose was efficiently incorporated into both glycan types from
both cell lines through the glycolysis pathway. MS/MS spectrum
of a fucosylated and sialylated N-glycan, Hex5HexNAc5Fuc1-
NeuAc2, demonstrated that glucose could be efficiently con-
verted to any type of monosaccharides including mannose,
GlcNAc, galactose, fucose, and sialic acid (Fig. S4a†). Exogenous
fructose and mannose, aer conversion to fructose-6-P and
mannose-6-P, respectively, can also be converted to all other
sugars donors in the cell.34,52 Their incorporation mechanisms,Table 1 Comparison of incorporation mechanisms and efficiencies of
hepatic KKU-M213 cell lines
13C-Saccharide
Incorporation mechanism
% Incorporatio
Man8GlcNAc2
Caco-2 M213 Caco-2 M2
UL-13C-Glc Glycolysis Glycolysis 86% 98%
UL-13C-Man Glycolysis Glycolysis & intact 82% 95%
UL-13C-Gal Glycolysis Intact 80% 37%
UL-13C-Fruc Glycolysis Glycolysis & intact 84% 91%
6998 | Chem. Sci., 2019, 10, 6992–7002however, were found to be different between intestinal Caco-2
and hepatic M213 cells. In intestinal cells, the glycolysis
pathway was dominant for both monosaccharides. While in
hepatic cells, direct incorporation of mannose into high
mannose N-glycans and the intact conversion of fructose to
mannose became more prominent. (Fig. S4b and S5†) The
intact conversion of mannose to galactose, GlcNAc, and fucose
was also found to be more efficient than its conversion to sialic
acid. Despite the differential metabolic pathways, the incorpo-
ration levels of fructose and mannose remained high in both
cell lines when no glucose was provided. However, when the
cells were supplemented with both 13C-fructose and unlabeled
glucose, the incorporation of fructose dramatically decreased
for both cells even though the concentration of fructose wasuniformly labeled (UL) 13C-monosaccharides in intestinal Caco-2 and
n % (Number of 13C/total number of C)
Hex5HexNAc4-
Fuc1NeuAc1 Man8GlcNAc2
Hex5HexNAc4-
Fuc1NeuAc1
13 Caco-2 M213 Caco-2 M213 Caco-2 M213
86% 97% 91% 97% 86% 95%
78% 97% 88% 84% 72% 68%
75% 82% 88% 9% 80% 15%
76% 92% 86% 86% 72% 83%
This journal is © The Royal Society of Chemistry 2019
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View Article Onlinemuch higher than glucose (25 mM vs. 10 mM). (Fig. S6†) Similar
results were observed for 13C-mannose, demonstrating the
preferential utilization of glucose by the cell as a carbon source.
More distinct features of incorporation were observed for
13C-galactose-treated cells. While in Caco-2 cell it was incorpo-
rated in the same way as the other three monosaccharides
through the glycolysis pathway, it could only be utilized as an
intact residue in M213 cells. For the high mannose type N-
glycan where there is no galactose residue, the incorporation
level was only 37% with six carbons replaced by 13C (Table 1).
For the complex type N-glycan with two galactose residues,
however, incorporation of six or twelve 13C was observed with
a total incorporation level of 82%, demonstrating the direct
incorporation of galactose in the hepatic cell.
Discussion
In this study, we present a stable isotope-labeling method to
elucidate the incorporation of exogenous monosaccharides to
cell membrane glycoproteins and evaluate the utilization effi-
ciencies of different saccharides thereby yielding their relative
contributions in different metabolic pathways. These glycomic
and glycoproteomic approaches are providing previously
unobtainable information regarding monosaccharide utiliza-
tion in the formation of glycoproteins. By combining metabolic
isotope-labeling of glycoproteins with glycomic and glyco-
proteomic analyses by LC-MS/MS, we were able to unveil the
metabolic origins and turnover kinetics of specic glycans and
glycoproteins on the cell membrane. The results showed glycan-
and protein-specic turnover rates of membrane glycoproteins
and unique 13C-incorporation patterns of different saccharides
in intestinal and hepatic cells. This stable isotope-labeling
method is readily applicable to in vivo studies to investigate
tissue-specic utilization of dietary saccharides. In combination
with studies on the functions of different glycosylation patterns,
this method will provide valuable guidance for dietary manip-
ulation of glycosylation and fate mapping of exogenous
supplements.
Dietary saccharides are not only an essential energy source but
also the major carbon source of the cell. Small differences in the
structure of exogenous monosaccharides can have a signicant
impact on cell glycosylation and potentially function. Under-
standing the metabolic pathways of dietary saccharides for
incorporating into membrane glycoproteins may be necessary for
controlling glycosylation and avoiding possible disorders caused
by diet. Earlier advancements in glycobiology have revealed the
metabolic pathways of common monosaccharides for the
synthesis of nucleotide sugar donors, the critical precursors for
glycosylation.12 However, less is known regarding the relative
contributions of the pathways in different organisms. For
example, glucose and mannose are both used in a multitude of
glycan structures. Their phosphate forms, Glc-6-phosphate and
Man-6-phosphate are the central molecules in the mono-
saccharide biosynthesis pathways and can be converted to all
other sugars. The results presented here indicate that fucosylated
and sialylated N-glycans employ glucose and mannose through
the glycolysis pathways at least in the cell lines studied here.This journal is © The Royal Society of Chemistry 2019However, with N-glycans that contain multiple mannose residues
as in high mannose glycans, intact incorporation of exogenous
mannose was signicant in M213 cells. The cell-dependent
incorporation of monosaccharides was also demonstrated for
galactose and fructose, where in the intestinal epithelial cell
glycolysis is always the dominant pathway while in the hepatic
cell more intact incorporation was observed.
The monosaccharides included in these studies can repre-
sent different components of diet. Glucose is found primarily as
starch, while fructose is found in fruits and vegetables.
Mannose is found in all types of glycoprotein-containing food
products and galactose is a monosaccharide component of
lactose from dairy products.53 While this notion is simplistic, it
does point to variations in utilization of various mono-
saccharides from diet that is both glycoconjugate- and tissue-
specic. Furthermore, we have previously shown that feeding
cells with different monosaccharides can alter the membrane
glycosylation.16 The implications are that diet can alter the
membrane glycosylation and therefore the cellular function.
Indeed, cell surface glycosylation can alter the migratory prop-
erties of cells, its ability to protect itself from infection, and its
ability to migrate.16,54,55 We can therefore infer that diet can
affect the fundamental properties of cell.
Experimental section
Cell culture
Human colorectal adenocarcinoma Caco-2 cells were obtained
from American Type Culture Collection (ATCC, VA) and grown
in Eagle's Minimum Essential Medium (EMEM) supplemented
with non-essential amino acids and 2 mM L-glutamine. Human
cholangiocarcinoma KKU-M213 cells were obtained from the
Japanese Collection of Research Bioresources Cell Bank (JCRB,
Osaka, Japan) and grown in Ham's F12 medium. All the media
were supplemented with 10% (v/v) fetal bovine serum and 100 U
mL1 penicillin and streptomycin. Cells were subcultured at
80% conuency and maintained at 37 C in a humidied
incubator with 5% CO2.
Isotope labeling of cell surface glycoproteins
For isotope labeling experiments, all the cells were cultured in
Dulbecco's Modied Eagle's Medium (DMEM) containing 25 mM
glucose for 24 h before treated with glucose-free DMEM supple-
mented with specic 13C-labeled monosaccharides (Omicron
Biochemicals, IN) at concentration of 25 mM for 72 h unless
specied otherwise. Controls were cultured in DMEM containing
25 mM glucose for the same amount of time before both the
control and treated cells were harvested by scraping. For the time-
course study using 25 mM of uniformly labeled glucose (13C6-
glucose), cells were washed three times with PBS and harvested
by scraping aer 3, 6, 12, 24, 48, 72, and 96 h of treatment.
Cell membrane extraction
Extraction of the cell membrane fraction was performed as
described previously with modied procedures.43,56 In brief,
harvested cells were resuspended in homogenization bufferChem. Sci., 2019, 10, 6992–7002 | 6999
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View Article Onlinecontaining 0.25 M sucrose, 20 mM HEPES-KOH (pH 7.4), and
1 : 100 protease inhibitor (EMD Millipore, CA). Cell lysis was
performed on ice using a probe sonicator (Qsonica, CT) with ve
alternating on and off pulses in 5 and 10 s intervals, respec-
tively. Whole cell lysates were centrifuged at 2000g for 10 min
to remove the nuclear fractions and cellular debris. The
supernatant was collected for ultracentrifugation at 200 000g
for 45 min at 4 C. The pellet was resuspended and repelleted by
ultracentrifugation using the same conditions in 0.2 M Na2CO3
(pH 11) followed by water to fragment the endoplasmic retic-
ulum and remove the cytoplasmic fraction, respectively. The
resulting membrane fraction was isolated and stored at 20 C
until further processing.Enzymatic release and purication of N-Glycans
Membrane pellets were resuspended in 100 mL of 100 mM
ammonium bicarbonate with 5 mM dithiothreitol and heated
for 10 s at 100 C to thermally denature the proteins. To release
the N-glycans from membrane proteins, 2 mL of peptide N-
glycosidase F (New England Biolabs, MA) were added to the
samples and incubated at 37 C in a microwave reactor (CEM
Corporation, NC) for 10min at 20 watts. Aer addition of 350 mL
of nanopore water, samples were ultracentrifuged at 200 000g
for 45 min at 4 C to precipitate the membrane fractions with
lipids and residual deglycosylated proteins. The supernatant
containing the released N-glycans was collected. N-Glycans were
puried by solid phase extraction containing a porous graphi-
tized carbon (PGC) matrix (Grace, IL). Eluted fractions were
dried in vacuo before they were reconstituted in 30 mL of
nanopore water and analyzed by LC-MS/MS.Glycomic analysis by LC-MS/MS
For N-glycan analysis, 5 mL of each reconstituted sample was
injected to an Agilent nanoLC/ESI-QTOF-MS system (Agilent
Technologies, CA) equipped with a microuidic chip, which
consists of an enrichment and an analytical column both
packed with porous graphitized carbon. A binary gradient was
applied to separate and elute glycans at a ow rate of 0.3
mL min1 using solvents (A) 3% (v/v) acetonitrile and 0.1% (v/v)
formic acid in water and (B) 90% (v/v) acetonitrile in 1% (v/v)
formic acid in water. MS spectra were acquired at 1.5 s per
spectrum over a mass range of m/z 600–2000 in positive ioni-
zation mode. Collision-induced dissociation (CID) was per-
formed with nitrogen gas using a series of collision energies
(Vcollision) dependent on the m/z values of the N-glycans, based
on the equation: Vcollision ¼ m/z (1.8/100 Da) V  2.4 V.Glycomic data analysis
N-Glycans in the control samples were identied with an in-
house library using MassHunter Qualitative Analysis B.06.01
(Agilent Technologies, CA). Deconvoluted masses were
compared to the theoretical masses using a mass tolerance of
10 ppm. Area under the peak was used to represent the abun-
dance of each glycan. Tandem MS spectra were used to conrm
the compositions and putative structures of the glycans.7000 | Chem. Sci., 2019, 10, 6992–7002Preparation of glycopeptides
Portions of the extracted plasma membrane fractions were
suspended in 60 mL of 8 M urea, reduced with 18 mM dithio-
threitol at 55 C for 50 min, alkylated with 27 mM iodoaceta-
mide at room temperature for 30 min, diluted to 1 M urea with
50 mM ammonium bicarbonate, and incubated with 2 mg
trypsin at 37 C overnight. The resulting glycopeptides were
enriched by solid-phased extraction using iSPE-HILIC
cartridges and dried in vacuo.
Glycoproteomic analysis by LC-MS/MS
Glycopeptides were dissolved in 2% (v/v) acetonitrile and 0.1%
(v/v) triuoroacetic acid in water and separated using a reverse-
phase Michrom Magic C18 AQ column (200 mm, 150 mm)
coupled with a Q Exactive Plus mass spectrometer through
a Proxeon nano-spray source (Thermo Scientic, CA). A binary
gradient was applied at a constant ow rate of 300 nl min1
using 0.1% (v/v) formic acid in (A) water and (B) 100% aceto-
nitrile. MS spectra were acquired over a mass range of m/z 350–
1600 in positive ionization mode. Higher-energy collisional
dissociation (HCD) with stepped collision energies (17, 27, 37)
was performed in data-dependent acquisition mode.
Glycoproteomic data analysis
Glycoproteins and glycopeptides were identied from the
tandem mass spectra using Byonic soware (Protein Metrics,
CA) against the reviewed Swiss-Prot human protein database
(20 207 entries) with sample-specic parameters as determined
from Byonic Preview (Protein Metrics, CA): mass tolerances of
5–10 ppm for the precursor and 10–20 ppm for fragment ions;
peptide probability >0.95; carbamidomethylation of cysteine as
a xed modication; oxidation of methionine and tryptophan,
deamidation of asparagine and glutamine, acetylation of the
protein N-terminus, and ammonia loss of cysteine as variable
modications; N-glycosylation of asparagine (in-house human
database of 369 entries); two missed cleavage sites. Identica-
tions were ltered with a 1% false discovery rate and were
accepted if their Log[Prob] values were greater than 2.
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